Skip to main content

Table 2 Clinical data of individuals included in cohort II

From: Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers

 

NC, n = 7

AD, n = 16

Age (years)

78 ± 9

80 ± 11a

Females (%)

57

56

APOEε4 carriers (%)

14

69

PMD (h)

6.11 ± 1.30

6.06 ± 1.25a

  1. AD Alzheimer’s disease, APOE4 apolipoprotein 4, NC non-demented control, PMD postmortem delay
  2. aData were analysed using Student’s t-test, and values are presented as mean value ± SD
  3. *Significant at p ≤ 0.05 level
  4. **Significant at p ≤ 0.01 level
  5. ***Significant at p ≤ 0.001 level
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193